World's Best Scientists 2026 revealed!
Award Badge
Medicine
UK
2023

D-Index & Metrics

Medicine

D-Index
151
Citations
116574
World Ranking
1099
National Ranking
116

Research.com Recognitions

  • 2023 - Research.com Medicine in United Kingdom Leader Award

Overview

Clive Ballard is affiliated with the University of Exeter in the United Kingdom. Their research focuses predominantly on the field of medicine, with significant contributions across psychiatry and mental health, neurology, physiology, clinical psychology, and molecular biology.

Their scholarly work covers several main topics, including:

  • Dementia and Cognitive Impairment Research
  • Alzheimer's disease research and treatments
  • Schizophrenia research and treatment
  • Parkinson's Disease Mechanisms and Treatments
  • Health disparities and outcomes
  • Aging and Gerontology Research
  • Geriatric Care and Nursing Homes

Some of Ballard's recent published papers include:

  • Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020, The Lancet)
  • Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science (2020, The Lancet Psychiatry)
  • Parkinson disease-associated cognitive impairment (2021, Nature Reviews Disease Primers)
  • Research criteria for the diagnosis of prodromal dementia with Lewy bodies (2020, Neurology)
  • Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study (2021, The Lancet Respiratory Medicine)

Frequent collaborators in their research include:

  • Dag Aarsland
  • Anne Corbett
  • Byron Creese
  • Adam Hampshire
  • Helen Brooker

Ballard has been published multiple times in recognized journals and platforms such as:

  • Alzheimer's & Dementia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • International Psychogeriatrics
  • International Journal of Geriatric Psychiatry
  • Journal of the American Medical Directors Association

Best Publications

  • Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.

    Gill Livingston;Gill Livingston;Jonathan Huntley;Andrew Sommerlad;Andrew Sommerlad;David Ames

  • Dementia prevention, intervention, and care

    Gill Livingston;Gill Livingston;Andrew Sommerlad;Vasiliki Orgeta;Sergi G Costafreda;Sergi G Costafreda

  • Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

    I. G. McKeith;I. G. McKeith;D. W. Dickson;J. Lowe;M. Emre

  • Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science.

    Emily A. Holmes;Emily A. Holmes;Rory C O'Connor;V. Hugh Perry;Irene Tracey

  • Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report of the consortium on DLB international workshop

    I. G. Mckeith;D. Galasko;K. Kosaka;E. K. Perry

  • Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

    Ian G. McKeith;Bradley F. Boeve;Dennis W. DIckson;Glenda Halliday

  • SeminarAlzheimer's disease

    Clive Ballard;Serge Gauthier;Anne Corbett;Carol Brayne

  • Vascular Cognitive Impairment

    John T O'Brien;Timo Erkinjuntti;Barry Reisberg;Gustavo Roman

  • Defeating Alzheimer's disease and other dementias: a priority for European science and society

    Bengt Winblad;Bengt Winblad;Philippe Amouyel;Sandrine Andrieu;Clive Ballard

  • Putting brain training to the test

    Adrian M. Owen;Adam Hampshire;Jessica A. Grahn;Robert Stenton

  • Parkinson disease-associated cognitive impairment.

    Dag Aarsland;Dag Aarsland;Lucia Batzu;Glenda M Halliday;Gert J Geurtsen

  • Cognitive decline in Parkinson disease

    Dag Aarsland;Byron Creese;Byron Creese;Marios Politis;K. Ray Chaudhuri

  • Donepezil and memantine for moderate-to-severe Alzheimer's disease.

    Robert Howard;Rupert McShane;James Lindesay;Craig Ritchie

  • Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial

    Jeffrey L Cummings;Stuart Isaacson;Roger Mills;Hilde Williams

  • The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial

    Clive Ballard;Maria Luisa Hanney;Megan Theodoulou;Simon Douglas

  • The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.

    Clive Ballard;J Waite

  • Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial

    Jane Fossey;Clive Ballard;Edmund Juszczak;Ian James

  • Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa.

    Clive G. Ballard;John T. O'Brien;Katharina Reichelt;Elaine K. Perry

  • Overlap between pathology of Alzheimer disease and vascular dementia.

    Raj N. Kalaria;Clive Ballard

  • Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial

    Bettina S Husebo;Clive Ballard;Reidun Sandvik;Odd Bjarte Nilsen

Frequent Co-Authors

Dag Aarsland
Dag Aarsland King's College London
John T. O'Brien
John T. O'Brien University of Cambridge
Anne Corbett
Anne Corbett University of Exeter
Ian G. McKeith
Ian G. McKeith Newcastle University
Robert H. Perry
Robert H. Perry Newcastle University
Paul T. Francis
Paul T. Francis University of Exeter
Keith Wesnes
Keith Wesnes University of Exeter
Elaine K. Perry
Elaine K. Perry Newcastle University
Rose Anne Kenny
Rose Anne Kenny Trinity College Dublin
Alistair Burns
Alistair Burns University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you explore your journey in Medicine, online degrees are becoming increasingly popular for advancing your healthcare education and expanding career options. A key consideration is program recognition. Prospective students often ask, which online healthcare degree programs are recognized for their accreditation by cahme? Accreditation ensures your degree meets quality standards and is respected by employers.

For registered nurses looking to move ahead, rn to bsn programs offer a flexible way to earn a bachelor’s degree without additional clinical requirements. This pathway can open up advanced roles and higher salaries.

Those seeking a terminal nursing degree may be interested in accelerated options, such as a 1 year dnp program online. These intensive programs are designed for experienced professionals wanting to quickly reach the highest levels of clinical practice.

Additionally, some professionals prefer streamlined programs, like dnp programs without dissertation. These focus on clinical expertise without the extensive research component, making them more accessible for busy practitioners.

Best Scientists Citing Clive Ballard

Trending Scientists

Recently Published Articles